- Home
- CBAT vs DOMH Comparison
CBAT vs DOMH Comparison
Compare CBAT & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAT
- DOMH
- Stock Information
- Founded
- CBAT 1999
- DOMH 1967
- Country
- CBAT China
- DOMH United States
- Employees
- CBAT N/A
- DOMH N/A
- Industry
- CBAT Industrial Machinery/Components
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- CBAT Miscellaneous
- DOMH Health Care
- Exchange
- CBAT Nasdaq
- DOMH Nasdaq
- Market Cap
- CBAT 83.0M
- DOMH 74.9M
- IPO Year
- CBAT N/A
- DOMH N/A
- Fundamental
- Price
- CBAT $0.86
- DOMH $8.20
- Analyst Decision
- CBAT
- DOMH
- Analyst Count
- CBAT 0
- DOMH 0
- Target Price
- CBAT N/A
- DOMH N/A
- AVG Volume (30 Days)
- CBAT 197.4K
- DOMH 4.4M
- Earning Date
- CBAT 03-14-2025
- DOMH 03-31-2025
- Dividend Yield
- CBAT N/A
- DOMH N/A
- EPS Growth
- CBAT N/A
- DOMH N/A
- EPS
- CBAT 0.12
- DOMH N/A
- Revenue
- CBAT $207,423,403.00
- DOMH $12,589,000.00
- Revenue This Year
- CBAT $0.46
- DOMH N/A
- Revenue Next Year
- CBAT $13.78
- DOMH N/A
- P/E Ratio
- CBAT $7.12
- DOMH N/A
- Revenue Growth
- CBAT 2.32
- DOMH 1117.50
- 52 Week Low
- CBAT $0.77
- DOMH $0.83
- 52 Week High
- CBAT $2.08
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- CBAT 41.36
- DOMH 58.54
- Support Level
- CBAT $0.85
- DOMH $8.25
- Resistance Level
- CBAT $0.92
- DOMH $12.00
- Average True Range (ATR)
- CBAT 0.04
- DOMH 2.15
- MACD
- CBAT -0.00
- DOMH 0.40
- Stochastic Oscillator
- CBAT 10.00
- DOMH 51.22
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization and distribution of a variety of standard and customized lithium-ion high-power rechargeable batteries. The company operates in two operating segments: CBAK's segment mainly includes the manufacture, commercialization and distribution of a wide variety of standard and customized lithium ion rechargeable batteries for use in a wide array of applications. Hitrans' segment mainly includes the development and manufacturing of NCM precursor and cathode materials. Geographically, it generates a majority of its revenue from Mainland China and also has an operation in Europe, the United States, Korea, and Other Countries.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.